Susquehanna International Group
SCMP

Susquehanna International Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Susquehanna International Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-24,100
Closed -$433K – 10824
2017
Q4 		$433K Sell
24,100
-1,400
-5% -$17.2K ﹤0.01% 6905
2017
Q3 		$301K Sell
25,500
-400
-2% -$4.49K ﹤0.01% 7392
2017
Q2 		$272K Sell
25,900
-18,600
-42% -$190K ﹤0.01% 7753
2017
Q1 		$490K Sell
44,500
-21,300
-32% -$247K ﹤0.01% 6524
2016
Q4 		$892K Buy
65,800
+32,200
+96% +$449K ﹤0.01% 5776
2016
Q3 		$414K Buy
33,600
+2,700
+9% +$31.8K ﹤0.01% 6403
2016
Q2 		$339K Sell
30,900
-8,800
-22% -$98.5K ﹤0.01% 6758
2016
Q1 		$434K Buy
39,700
+5,200
+15% +$65.7K ﹤0.01% 6654
2015
Q4 		$597K Buy
34,500
+5,700
+20% +$102K ﹤0.01% 6429
2015
Q3 		$572K Sell
28,800
-13,100
-31% -$300K ﹤0.01% 6864
2015
Q2 		$688K Sell
41,900
-7,000
-14% -$121K ﹤0.01% 6989
2015
Q1 		$761K Buy
48,900
+31,400
+179% +$487K ﹤0.01% 6301
2014
Q4 		$250K Buy
+17,500
New +$185K ﹤0.01% 8440
2014
Q3 		– Sell
-37,900
Closed -$262K – 10291
2014
Q2 		$262K Sell
37,900
-58,700
-61% -$415K ﹤0.01% 8613
2014
Q1 		$691K Buy
96,600
+86,500
+856% +$740K ﹤0.01% 6179
2013
Q4 		$95K Sell
10,100
-38,700
-79% -$276K ﹤0.01% 8653
2013
Q3 		$305K Buy
+48,800
New +$305K ﹤0.01% 7173

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Susquehanna International Group's SCMP Position: Q1 2018 in Review

Susquehanna International Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 176,051 shares — an estimated $3.16M sold.

Susquehanna International Group first reported a position in SCMP in Q4 2014 and held it in 11 quarters. The position peaked at $4.26M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Susquehanna International Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 176,051 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.16M.
  • Susquehanna International Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 11 quarters.
  • Susquehanna International Group's Sucampo Pharmaceuticals, Inc. position peaked at $4.26M in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.